SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-015757
Filing Date
2023-04-28
Accepted
2023-04-28 16:02:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A eypt_defa14a_04-28-2023.htm DEFA14A 25485
2 GRAPHIC img203172737_0.jpg GRAPHIC 2063805
3 GRAPHIC img203172737_1.jpg GRAPHIC 467804
  Complete submission text file 0000950170-23-015757.txt   3509593
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-51122 | Film No.: 23865752
SIC: 3826 Laboratory Analytical Instruments
Industrial Applications and Services